Malignancy Rates in children, young people, and adults with Juvenile Inflammatory Arthritis (JIA): an observational study using CPRD Aurum
Clicks: 1
ID: 316006
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #123 of 200 articles by views in Lara D. Veeken
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 200 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
OBJECTIVES: Juvenile Inflammatory Arthritis (JIA) affects ∼1-2/2,000 children in the UK. Adults with inflammatory arthritis have ∼10% increased malignancy risk. JIA malignancy rates in Nordic data are 3-5/10 000 person years, with conflicting evidence on comparative risk. This study calculated malignancy rates in England of patients with JIA, vs matched controls and general population estimates. METHODS: Using UK Primary Care data (CPRD) Aurum, this retrospective cohort study matched patients with JIA (diagnosed <16 years) 4-to-1 with non-JIA controls in England by birth year, gender, practice. Malignancies were identified from (i) NHS-linked hospitalisation data, and (ii) CPRD read codes. Exposure started at first JIA code date (or matched-date for controls), 1-Jan-2000, or CPRD entry date, whichever was latest. Follow-up continued until end of follow-up of JIA-matched patient (for controls), end of CPRD follow-up, 31-Dec-2018, first malignancy, or death, whichever was first. Cox-proportional hazards models compared malignancy rates. Standardised incidence ratios (SIRs) were calculated against ONS general population estimates by calendar year, age, gender. RESULTS: 3,714 patients with JIA and 10 858 matched controls were identified; demographics were similar. Malignancy rates were 6.8 per 10 000 (95%CI : 4.4-10.7) in JIA and 3.1 per 10 000 person years (95%CI : 2.0-4.6) in controls; HR 2.2 (95%CI : 1.2-4.1). Both cohorts had raised SIRs compared with ONS general population estimates. CONCLUSIONS: This study found that those with JIA had a doubling risk for malignancies compared with the matched control population. However, it is important to note that malignancy in this JIA patient population is extremely rare with the absolute risk remaining very low.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (70 words).
Try re-searching for a better abstract.
| Reference Key |
openalex_W7163642313
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lianne Kearsley-Fleet, Samuel WD Merriel, Natasha Shaw, Jasmine Leslie, Michelle Johnson, Lucy R Wedderburn, K Hyrich, Jenny H Humphreys |
| Journal | Lara D. Veeken |
| Year | 2026 |
| DOI |
10.1093/rheumatology/keag291
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.